Bucchi Annalisa, Baruscotti Mirko, Robinson Richard B, DiFrancesco Dario
Department of General Physiology and Biochemistry, Laboratory of Molecular Physiology and Neurobiology, University of Milan, via Celoria 26, Milano 20133, Italy.
J Mol Cell Cardiol. 2003 Aug;35(8):905-13. doi: 10.1016/s0022-2828(03)00150-0.
I(f) contributes to generation and autonomic control of spontaneous activity of cardiac pacemaker cells through a cAMP-dependent, Ca(2+)-independent mechanism of rate regulation. However, disruption of Ca(2+) release from sarcoplasmic reticulum (SR) by ryanodine (Ry) has been recently shown to slow spontaneous rate and inhibit beta-adrenergic receptor (betaAR)-induced rate acceleration, leading to the suggestion that the target of betaAR modulation of pacemaking is the intracellular Ca(2+)-regulatory process. We have investigated whether the Ry-induced decrease of betaAR rate modulation alternatively involves disruption of the betaAR-adenylate-cyclase-cAMP-I(f) mechanism. Prolonged exposure to Ry (3 microM, >2 min) slowed spontaneous rate of pacemaker cells by 29.8% via a depolarizing shift of take-off potential (TOP) without significantly changing early diastolic depolarization rate. Ry depressed rate acceleration caused by isoproterenol (Iso) (1 microM, 23.6% in control vs. 8.0%), but did not modify that caused by two membrane-permeable cAMP analogs, CPT-cAMP (300 microM, 17.7% vs. 17.3%) and Rp-cAMPs (50 microM, 18.0% vs. 20.6%). Consistent with the rate effect, exposure to Ry decreased the shift induced by Iso, but not that induced by either cAMP analog on the I(f)-activation curve. We conclude that disruption of Ry receptor function and SR Ca(2+) release depresses betaAR-induced modulation of heart rate, but does not impair cAMP-dependent rate acceleration mediated by I(f). However, abolishment of normal Ca(2+) homeostasis may result in the failure of betaAR agonists to sufficiently elevate cAMP near f-channels. The molecular basis for Ca(2+)-dependent interference in beta-adrenergic signaling remains to be determined.
I(f) 通过一种依赖于环磷酸腺苷(cAMP)且不依赖于钙离子(Ca(2+))的速率调节机制,参与心脏起搏细胞自发活动的产生和自主控制。然而,最近研究表明,用ryanodine(Ry)破坏肌浆网(SR)的钙离子释放,会减慢自发速率并抑制β-肾上腺素能受体(βAR)诱导的速率加速,这表明βAR对起搏的调节靶点是细胞内钙离子调节过程。我们研究了Ry诱导的βAR速率调节降低是否也涉及βAR - 腺苷酸环化酶 - cAMP - I(f) 机制的破坏。长时间暴露于Ry(3微摩尔,>2分钟)通过起飞电位(TOP)的去极化偏移使起搏细胞的自发速率减慢29.8%,而早期舒张期去极化速率没有显著变化。Ry抑制了异丙肾上腺素(Iso)(1微摩尔)引起的速率加速(对照组中为23.6%,而处理后为8.0%),但没有改变两种膜通透性cAMP类似物CPT - cAMP(300微摩尔,分别为17.7%和17.3%)和Rp - cAMPs(50微摩尔,分别为18.0%和20.6%)引起的速率加速。与速率效应一致,暴露于Ry会降低Iso诱导的I(f) - 激活曲线上的偏移,但不会降低任何一种cAMP类似物诱导的偏移。我们得出结论,Ry受体功能破坏和SR钙离子释放会抑制βAR诱导的心率调节,但不会损害由I(f)介导的依赖于cAMP的速率加速。然而,正常钙离子稳态的破坏可能导致βAR激动剂无法在f通道附近充分提高cAMP。β-肾上腺素能信号传导中钙离子依赖性干扰的分子基础仍有待确定。